Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal

por Ikenaga, Naoki, Peng, Zhen-Wei, Vaid, Kahini A, Liu, Susan B, Yoshida, Shuhei, Sverdlov, Deanna Y, Mikels-Vigdal, Amanda, Smith, Victoria, Schuppan, Detlef, Popov, Yury V
Publicado 2017

The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis

por Peng, Zhen‐Wei, Rothweiler, Sonja, Wei, Guangyan, Ikenaga, Naoki, Liu, Susan B., Sverdlov, Deanna Y., Vaid, Kahini A., Longhi, Maria Serena, Kuang, Ming, Robson, Simon C., Popov, Yury V.
Publicado 2017

Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease

por Kwong, Gabriel A., von Maltzahn, Geoffrey, Murugappan, Gayathree, Abudayyeh, Omar, Mo, Steven, Papayannopoulos, Ioannis A., Sverdlov, Deanna Y., Liu, Susan B., Warren, Andrew D., Popov, Yury, Schuppan, Detlef, Bhatia, Sangeeta N.
Publicado 2012